• What a controversial drug approval could mean for future Alzheimer's treatments

    23 hours ago - By Business Insider

    Welcome to Insider Healthcare. I'm Lydia Ramsey Pflanzer, and this week in healthcare news: A controversial Alzheimer's drug approval poses some big challenges for the future of the field ; We chronicled the history of Noom, which raised $540 million from top investors after spending a decade trying to crack the weight-loss app business ; Amazon and Walmart face off on discounting prescriptions. If you're new to this newsletter, sign up here. Tips, comments? Email me at lramsey insider.com or tweet lydiaramsey125. Let's get to it... We're still looking for nominees for our annual 30 under...
    Read more ...